NO20005263D0 - Nye substituerte amider, deres fremstilling og anvendelse - Google Patents
Nye substituerte amider, deres fremstilling og anvendelseInfo
- Publication number
- NO20005263D0 NO20005263D0 NO20005263A NO20005263A NO20005263D0 NO 20005263 D0 NO20005263 D0 NO 20005263D0 NO 20005263 A NO20005263 A NO 20005263A NO 20005263 A NO20005263 A NO 20005263A NO 20005263 D0 NO20005263 D0 NO 20005263D0
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- substituted
- hydrogen
- phenyl
- branched
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/36—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19818615 | 1998-04-20 | ||
PCT/EP1999/002633 WO1999054310A2 (de) | 1998-04-20 | 1999-04-20 | Neue substituierte amide, deren herstellung und anwendung |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20005263D0 true NO20005263D0 (no) | 2000-10-19 |
NO20005263L NO20005263L (no) | 2000-10-19 |
Family
ID=7865831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20005263A NO20005263L (no) | 1998-04-20 | 2000-10-19 | Nye substituerte amider, deres fremstilling og anvendelse |
Country Status (22)
Country | Link |
---|---|
US (4) | US6753327B1 (xx) |
EP (1) | EP1073641B1 (xx) |
JP (1) | JP4782924B2 (xx) |
KR (1) | KR20010042840A (xx) |
CN (1) | CN1306505A (xx) |
AT (1) | ATE264310T1 (xx) |
AU (1) | AU3927699A (xx) |
BG (1) | BG104873A (xx) |
BR (1) | BR9909774A (xx) |
CA (1) | CA2328396C (xx) |
DE (1) | DE59909183D1 (xx) |
ES (1) | ES2220061T3 (xx) |
HR (1) | HRP20000787A2 (xx) |
HU (1) | HUP0102732A3 (xx) |
ID (1) | ID26403A (xx) |
IL (1) | IL138703A0 (xx) |
NO (1) | NO20005263L (xx) |
PL (1) | PL343896A1 (xx) |
SK (1) | SK14512000A3 (xx) |
TR (1) | TR200003068T2 (xx) |
WO (1) | WO1999054310A2 (xx) |
ZA (1) | ZA200006719B (xx) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1073641B1 (de) | 1998-04-20 | 2004-04-14 | Abbott GmbH & Co. KG | Neue substituierte amide, deren herstellung und anwendung |
DE19817459A1 (de) * | 1998-04-20 | 1999-10-21 | Basf Ag | Neue heterozyklische substituierte Amide, Herstellung und Anwendung |
IL139357A0 (en) * | 1998-05-25 | 2001-11-25 | Basf Ag | New heterocyclically substituted amides, their production and their use |
DE10114762A1 (de) * | 2001-03-26 | 2002-10-02 | Knoll Gmbh | Verwendung von Cysteinprotease-Inhibitoren |
SE0102299D0 (sv) | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
US7282512B2 (en) | 2002-01-17 | 2007-10-16 | Smithkline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors |
US7109217B2 (en) * | 2002-11-12 | 2006-09-19 | Merck & Co., Inc. | Phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease |
NZ540148A (en) | 2002-12-20 | 2007-11-30 | Glaxo Group Ltd | Benzazepine derivatives for the treatment of neurological disorders |
US20040204422A1 (en) | 2003-04-14 | 2004-10-14 | Abbott Gmbh & Co. Kg. | N-[(Piperazinyl)hetaryl]arylsulfonamide compounds |
MY147780A (en) | 2006-12-29 | 2013-01-31 | Abbvie Deutschland | Carboxamide compounds and their use as calpain inhibitors |
TWI453019B (zh) | 2007-12-28 | 2014-09-21 | Abbvie Deutschland | 甲醯胺化合物 |
US20100192866A1 (en) * | 2009-02-03 | 2010-08-05 | Mcmullen Joseph E | Disposable hummingbird feeder |
TWI519530B (zh) | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途 |
US8236798B2 (en) | 2009-05-07 | 2012-08-07 | Abbott Gmbh & Co. Kg | Carboxamide compounds and their use as calpain inhibitors |
US9051304B2 (en) | 2009-12-22 | 2015-06-09 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors V |
US8598211B2 (en) | 2009-12-22 | 2013-12-03 | Abbvie Inc. | Carboxamide compounds and their use as calpain inhibitors IV |
EP2563446A1 (en) | 2010-04-30 | 2013-03-06 | Abbott Cardiovascular Systems Inc. | Improved balloon catheter exhibiting rapid inflation and deflation |
US9062027B2 (en) | 2010-12-09 | 2015-06-23 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors V |
SG11201406345XA (en) | 2012-04-03 | 2014-11-27 | Abbvie Deutschland | Carboxamide compounds and their use as calpain inhibitors v |
US9013997B2 (en) | 2012-06-01 | 2015-04-21 | Broadcom Corporation | System for performing distributed data cut-through |
WO2017156071A1 (en) | 2016-03-09 | 2017-09-14 | Blade Therapeutics, Inc. | Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof |
US11292801B2 (en) | 2016-07-05 | 2022-04-05 | Blade Therapeutics, Inc. | Calpain modulators and therapeutic uses thereof |
PE20191153A1 (es) | 2016-09-28 | 2019-09-05 | Blade Therapeutics Inc | Moduladores de calpainas y usos terapeuticos de los mismos |
WO2024018245A1 (en) * | 2022-07-22 | 2024-01-25 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of calpain inhibitors for the treatment of the diabetic kidney disease |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992011850A2 (en) | 1990-12-28 | 1992-07-23 | Cortex Pharmaceuticals, Inc. | Use of calpain inhibitors in the inhibition and treatment of neurodegeneration |
CA2098702A1 (en) | 1990-12-28 | 1992-06-29 | James C. Powers | Peptide ketoamides, ketoacids, and ketoesters |
EP0579724B2 (en) | 1991-04-10 | 2010-04-28 | Mayo Foundation For Medical Education And Research | Confocal imaging system for visible and ultraviolet light |
CA2071621C (en) * | 1991-06-19 | 1996-08-06 | Ahihiko Hosoda | Aldehyde derivatives |
AU4544993A (en) | 1992-06-24 | 1994-01-24 | Cortex Pharmaceuticals, Inc. | Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
US5541290A (en) | 1993-06-24 | 1996-07-30 | Harbeson; Scott L. | Optically pure calpain inhibitor compounds |
JP3216458B2 (ja) | 1994-12-28 | 2001-10-09 | 富士レビオ株式会社 | アミド誘導体 |
DE19642591A1 (de) | 1996-10-15 | 1998-04-16 | Basf Ag | Neue Piperidin-Ketocarbonsäure-Derivate, deren Herstellung und Anwendung |
EP1073641B1 (de) | 1998-04-20 | 2004-04-14 | Abbott GmbH & Co. KG | Neue substituierte amide, deren herstellung und anwendung |
DE19817459A1 (de) * | 1998-04-20 | 1999-10-21 | Basf Ag | Neue heterozyklische substituierte Amide, Herstellung und Anwendung |
IL139357A0 (en) * | 1998-05-25 | 2001-11-25 | Basf Ag | New heterocyclically substituted amides, their production and their use |
-
1999
- 1999-04-20 EP EP99922108A patent/EP1073641B1/de not_active Expired - Lifetime
- 1999-04-20 KR KR1020007011607A patent/KR20010042840A/ko not_active Application Discontinuation
- 1999-04-20 PL PL99343896A patent/PL343896A1/xx unknown
- 1999-04-20 IL IL13870399A patent/IL138703A0/xx unknown
- 1999-04-20 ES ES99922108T patent/ES2220061T3/es not_active Expired - Lifetime
- 1999-04-20 JP JP2000544649A patent/JP4782924B2/ja not_active Expired - Fee Related
- 1999-04-20 AU AU39276/99A patent/AU3927699A/en not_active Abandoned
- 1999-04-20 US US09/673,089 patent/US6753327B1/en not_active Expired - Fee Related
- 1999-04-20 ID IDW20002132A patent/ID26403A/id unknown
- 1999-04-20 DE DE59909183T patent/DE59909183D1/de not_active Expired - Lifetime
- 1999-04-20 AT AT99922108T patent/ATE264310T1/de not_active IP Right Cessation
- 1999-04-20 SK SK1451-2000A patent/SK14512000A3/sk unknown
- 1999-04-20 TR TR2000/03068T patent/TR200003068T2/xx unknown
- 1999-04-20 BR BR9909774-5A patent/BR9909774A/pt not_active IP Right Cessation
- 1999-04-20 CA CA002328396A patent/CA2328396C/en not_active Expired - Fee Related
- 1999-04-20 WO PCT/EP1999/002633 patent/WO1999054310A2/de not_active Application Discontinuation
- 1999-04-20 HU HU0102732A patent/HUP0102732A3/hu unknown
- 1999-04-20 CN CN99807639A patent/CN1306505A/zh active Pending
-
2000
- 2000-10-17 BG BG104873A patent/BG104873A/xx unknown
- 2000-10-19 NO NO20005263A patent/NO20005263L/no not_active Application Discontinuation
- 2000-11-17 HR HR20000787A patent/HRP20000787A2/hr not_active Application Discontinuation
- 2000-11-17 ZA ZA200006719A patent/ZA200006719B/xx unknown
-
2003
- 2003-10-20 US US10/690,400 patent/US7276500B2/en not_active Expired - Fee Related
-
2007
- 2007-08-29 US US11/897,057 patent/US7956093B2/en not_active Expired - Fee Related
-
2010
- 2010-10-29 US US12/915,680 patent/US20110275615A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ZA200006719B (en) | 2002-08-15 |
EP1073641B1 (de) | 2004-04-14 |
US6753327B1 (en) | 2004-06-22 |
JP4782924B2 (ja) | 2011-09-28 |
TR200003068T2 (tr) | 2001-03-21 |
WO1999054310A2 (de) | 1999-10-28 |
ES2220061T3 (es) | 2004-12-01 |
KR20010042840A (ko) | 2001-05-25 |
ATE264310T1 (de) | 2004-04-15 |
EP1073641A2 (de) | 2001-02-07 |
ID26403A (id) | 2000-12-21 |
US20110275615A1 (en) | 2011-11-10 |
NO20005263L (no) | 2000-10-19 |
IL138703A0 (en) | 2001-10-31 |
US7956093B2 (en) | 2011-06-07 |
HUP0102732A3 (en) | 2002-12-28 |
JP2002512231A (ja) | 2002-04-23 |
AU3927699A (en) | 1999-11-08 |
BG104873A (en) | 2001-07-31 |
WO1999054310A3 (de) | 2000-02-17 |
US7276500B2 (en) | 2007-10-02 |
HRP20000787A2 (en) | 2001-08-31 |
CA2328396C (en) | 2009-02-10 |
US20040082569A1 (en) | 2004-04-29 |
CA2328396A1 (en) | 1999-10-28 |
HUP0102732A2 (hu) | 2001-12-28 |
BR9909774A (pt) | 2000-12-19 |
SK14512000A3 (sk) | 2001-04-09 |
US20080113989A1 (en) | 2008-05-15 |
PL343896A1 (en) | 2001-09-10 |
CN1306505A (zh) | 2001-08-01 |
DE59909183D1 (de) | 2004-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20005263D0 (no) | Nye substituerte amider, deres fremstilling og anvendelse | |
CO5140126A1 (es) | 2-fenilbenzimidazoles sustituidos, su obtencion y uso | |
PL289323A1 (en) | Method of synthesizing new derivatives of n-/4-peperidine//dihydrate benzofuran or dihydrate -2h-benzopyrone/ carbon amides | |
AU4929690A (en) | Phenyl pyradazine-3(2H)one, thiadizin-2(3H)one, triazin-3(2H) one and oxadiazin-5(4H)one derivatives for the treatment of congestive heart failure | |
ATE375980T1 (de) | Nicotinamide und deren verwendung als p38 inhibitoren | |
NZ335973A (en) | Indane or dihydroindole derivatives and their use in treating neurological and cardiovascular disorders | |
TW326447B (en) | Substituted 2-phenylpyridines, intermediates and process for their preparation and application thereof | |
DE69413414D1 (de) | Substituierte phenylverbindungen | |
AP2001002265A0 (en) | Phenoxybenzylamine derivatives as SSRIs. | |
MXPA04004593A (es) | Triazoles fenilo-sustituidos y su uso como inhibidores selectivos de cinasa de tipo activina-5. | |
FI913957A (fi) | 6,7-dihydro-3-fenyl-1,2 -bensisoxazol-4(5h)-oner och -oler, foerfarande foer framstaellning av dessa samt anvaendning av dessa som laekemedel. | |
TW340109B (en) | Amide derivatives and their therapeutic use | |
DK0493925T3 (da) | Pyrazolderivater med herbicid aktivitet, deres fremstilling og anvendelse | |
IL116907A0 (en) | Substituted phenyl compounds | |
DE602004017966D1 (de) | Neue aminopyridinderivate als mglur5-antagonisten | |
EA200600171A1 (ru) | 3-замещенные пиримидины | |
IL141009A0 (en) | N-substituted azabicycloheptane derivatives, production and use thereof | |
FR2543139B1 (fr) | Derives de (1-alcoxy 2-amino) ethyl pyridine ou pyrazine, leur preparation et leur application en therapeutique | |
RS86904A (xx) | Derivati 3-heteroaril-3,5-dihidro-4-okso-4h-piridazino (4,5- b)-indol-1-acetamida, njihovo dobijanje i primena u terapiji | |
HU0001127D0 (en) | Process for producing n-[5-(diphenyl-phosphinoyl-methyl)-4-(4-fluorphenyl-6-isopropyl-pyrimidin-2-yl]-n-methylmethan sulfonamid | |
YU110792A (sh) | Supstituisani 4(5)amino-1,8-naftiridini formule i postupak za njihovu proizvodnju |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |